Pulmonx (LUNG) vs SkinHealth Systems (SKIN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Pulmonx (LUNG) has outperformed SkinHealth Systems (SKIN) over the past year, gaining 1.7% versus a loss of 66.5%. Over five years, LUNG leads with a -95.5% price change compared with -97.8% for SKIN. Pulmonx is the larger company by market cap ($77.7 million vs $74.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LUNG | SKIN |
|---|---|---|
| Share price | $1.81 | $0.5689 |
| Market cap | $77.74M | $74.04M |
| 1-day change | -1.63% | -3.56% |
| YTD return | -18.10% | -59.07% |
| 1-year return | +1.69% | -66.54% |
| 5-year return | -95.45% | -97.78% |
| Forward P/E | — | 2.99 |
| EPS (TTM) | $-1.19 | $-0.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.89 | $1.74 |
| 52-week low | $1.13 | $0.55 |
| Distance from 52-week high | -37.37% | -67.30% |
| Analyst consensus | none | none |
| Avg. price target upside | +87.85% | +74.02% |
| Average volume | 477.26K | 489.80K |
| Shares outstanding | 42.95M | 130.14M |
| Employees | 296 | 613 |
| Sector | Healthcare | Consumer Defensive |
| Industry | Medical Devices | Household & Personal Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LUNG has outperformed SKIN by 68.2 percentage points over the past year.
- The two companies sit in different sectors: Pulmonx in Healthcare and SkinHealth Systems in Consumer Defensive.
About Pulmonx
LUNG stock →Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease. It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.
Healthcare · Medical Devices · 296 employees
About SkinHealth Systems
SKIN stock →SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums.
Consumer Defensive · Household & Personal Products · 613 employees
LUNG vs SKIN FAQ
Which is bigger, Pulmonx or SkinHealth Systems?
Pulmonx (LUNG) is larger, with a market capitalization of $77.74M compared with $74.04M for SkinHealth Systems (SKIN).
Which stock has performed better over the past year, LUNG or SKIN?
LUNG returned +1.69% over the past 12 months, compared with -66.54% for SKIN (price return, excluding dividends). Past performance does not predict future results.
Are Pulmonx and SkinHealth Systems in the same industry?
No. Pulmonx is in the Healthcare sector, while SkinHealth Systems is in Consumer Defensive.